Jane Street’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Jane Street’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,503	Closed	-$106K	–	11217
2021 Q4	$106K	Sell	1,503 -5,510	-79%	-$464K	﹤0.01%	9224
2021 Q3	$654K	Sell	7,013 -4,990	-42%	-$474K	﹤0.01%	6769
2021 Q2	$1.21M	Buy	12,003 +10,246	+583%	+$999K	﹤0.01%	5425
2021 Q1	$164K	Sell	1,757 -763	-30%	-$77.4K	﹤0.01%	8407
2020 Q4	$208K	Sell	2,520 -2,737	-52%	-$233K	﹤0.01%	6909
2020 Q3	$451K	Buy	+5,257	New	+$613K	﹤0.01%	5310

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's VBIV Position: Q3 2023 in Review

Jane Street sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 12,191 shares — an estimated $40.1K sold.

Jane Street first reported a position in VBIV in Q2 2018 and held it in 16 quarters. The position peaked at $674K in Q2 2021. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

Jane Street reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
Jane Street sold 12,191 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $40.1K.
Jane Street first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 16 quarters.
Jane Street's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $674K in Q2 2021.
37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.